Biotech News

Progyny to Discuss Updated Financial Expectations at Upcoming JP Morgan Healthcare Conference

Progyny (PGNY)Progyny2026-01-12 13:00 ESTConference / presentation

Anticipates Fourth Quarter and Full Year Results to Be Slightly Above Previously Provided Financial Guidance NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a global leader in women’s health and family building solutions, today announced that

Related news

PGNYProgyny2026-09-03 15:17 EST

Progyny, Inc. to Present at the Wells Fargo Healthcare Conference

PGNYProgyny2025-11-13 17:33 EST

Progyny, Inc. to Present at Jefferies Global Healthcare Conference

COOThe Cooper Companies2025-12-29 21:15 EST

CooperCompanies to Present at the J.P. Morgan Healthcare Conference

DAREDare Bioscience, Inc.2020-01-15 13:00 EST

Daré Bioscience Schedules Conference Call for January 22, 2020 to Discuss Ovaprene® Licensing Agreement and General Corporate Update

TDOCTeladoc2026-03-03 21:05 EST

Teladoc Health to Participate in Upcoming Investor Conference

COOThe Cooper Companies2025-08-14 20:15 EST

CooperCompanies to Participate in the Wells Fargo Healthcare Conference

DAREDare Bioscience, Inc.2020-02-05 13:00 EST

Daré Bioscience to Present at the 2020 BIO CEO & Investor Conference

SERASera Prognostics2026-02-17 13:05 EST

SERA PROGNOSTICS TO PRESENT AT TD COWEN 46th ANNUAL HEALTH CARE CONFERENCE

SERASera Prognostics2026-10-21 20:05 EST

SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF THIRD QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON NOVEMBER 4, 2026

TDOCTeladoc2026-10-14 20:05 EST

Teladoc Health to Announce Third Quarter 2026 Financial Results

View all latest news

Progyny

Women's Health and Family Building Progyny manages employer-sponsored benefits for fertility, family building and women's health. Its programs are designed to guide members through complex care while helping benefit purchasers manage quality and cost. Integrated Benefit Platform The company's services include fertility treatment,...

Recent company news

PGNYProgyny2026-11-04 21:01 EST

Progyny, Inc. Announces Third Quarter 2026 Results

PGNYProgyny2026-10-28 13:52 EST

New Progyny Study Examines Persistent Racial and Ethnic Differences in Fertility Treatment Initiation Despite Access to Benefits

PGNYProgyny2026-10-26 15:25 EST

New Progyny Study Finds Significant Improvement in Menopause Symptoms Through Connected Care Model

PGNYProgyny2026-10-21 14:43 EST

Progyny, Inc. Announces Details for Its Third Quarter 2026 Results Report

PGNYProgyny2026-10-15 13:35 EST

Progyny to Present New Menopause Research at The Menopause Society 2026 Annual Meeting

Stock data

Close: 34.37 USD
Market cap: 1.97B USD
Exchange: NASDAQ
Sector: Biopharma
Location: United States